moxifloxacin has been researched along with thiophenes in 7 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (thiophenes) | Trials (thiophenes) | Recent Studies (post-2010) (thiophenes) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 17,012 | 1,961 | 8,038 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Callaghan, JT; Chappell, J; Derby, M; Desaiah, D; Ereshefsky, L; Francis, JL; Gonzales, CR; Hoelscher, D; Knadler, MP; Leese, PT; Leibowitz, M; Small, D; Zhang, L | 1 |
Becka, M; Kubitza, D; Mueck, W | 1 |
Andreas, JO; Braun, M; Cawello, W; Hnatkova, K; Hoeckendorff, J; Horstmann, R; Malik, M; Middle, M | 1 |
Bentley, D; Jordan, P; Ruf, T; Russell-Yarde, F; Sturm, S | 1 |
Arezina, R; Camm, AJ; Lorch, U; Naseem, A; Taubel, J; Wang, D | 1 |
Abeyratne, A; Dietz, A; Kadokura, T; Keirns, J; Krauwinkel, W; Smulders, R; Zhang, W | 1 |
Batich, C; Bechtle, A; Eiferman, R; Gibson, D; Guidi, C; Schultz, G; Stanton, D; Yang, Q | 1 |
6 trial(s) available for moxifloxacin and thiophenes
Article | Year |
---|---|
QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Infective Agents; Antidepressive Agents; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Electrocardiography; Female; Fluoroquinolones; Guideline Adherence; Humans; Middle Aged; Moxifloxacin; Practice Guidelines as Topic; Quinolines; Thiophenes | 2007 |
Randomized, double-blind, crossover study to investigate the effect of rivaroxaban on QT-interval prolongation.
Topics: Administration, Oral; Aged; Algorithms; Antithrombin III; Aza Compounds; Blood Coagulation; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Male; Metabolic Clearance Rate; Middle Aged; Morpholines; Moxifloxacin; Prospective Studies; Quinolines; Rivaroxaban; Sex Factors; Thiophenes; Time Factors | 2008 |
Thorough QT/QTc study in patients with advanced Parkinson's disease: cardiac safety of rotigotine.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Dopamine Agonists; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Male; Middle Aged; Moxifloxacin; Parkinson Disease; Quinolines; Tetrahydronaphthalenes; Thiophenes | 2008 |
No evidence of QT prolongation with supratherapeutic doses of aleglitazar.
Topics: Adult; Aza Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Oxazoles; PPAR alpha; PPAR gamma; Quinolines; Thiophenes; Time Factors; Young Adult | 2012 |
Repeated supratherapeutic dosing of strontium ranelate over 15 days does not prolong QT(c) interval in healthy volunteers.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Aza Compounds; Bone Density Conservation Agents; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Linear Models; London; Long QT Syndrome; Male; Moxifloxacin; Nonlinear Dynamics; Organometallic Compounds; Patient Safety; Predictive Value of Tests; Quinolines; Risk Assessment; Risk Factors; Thiophenes; Young Adult | 2012 |
Ipragliflozin does not prolong QTc interval in healthy male and female subjects: a phase I study.
Topics: Adult; Aza Compounds; Black or African American; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Fluoroquinolones; Glucosides; Healthy Volunteers; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Thiophenes; White People; Young Adult | 2013 |
1 other study(ies) available for moxifloxacin and thiophenes
Article | Year |
---|---|
A Novel Method to Eliminate Preservatives in Eye Drops.
Topics: Anti-Bacterial Agents; Bacteria; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ophthalmic Solutions; Preservatives, Pharmaceutical; Sulfonamides; Thiophenes; Timolol | 2018 |